Lachmann N - Search Results

1

Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection.

Waiser J, Budde K, Schütz M, Liefeldt L, Rudolph B, Schönemann C, Neumayer HH, Lachmann N. Waiser J, et al. Among authors: lachmann n. Nephrol Dial Transplant. 2012 Mar;27(3):1246-51. doi: 10.1093/ndt/gfr465. Epub 2011 Aug 17. Nephrol Dial Transplant. 2012. PMID: 21852274

2

Flow cytometric detection of complement-activating HLA antibodies.

Schönemann C, Lachmann N, Kiesewetter H, Salama A. Schönemann C, et al. Among authors: lachmann n. Cytometry B Clin Cytom. 2004 Nov;62(1):39-45. doi: 10.1002/cyto.b.20027. Cytometry B Clin Cytom. 2004. PMID: 15476206 Free article.

3

Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up.

Lachmann N, Terasaki PI, Schönemann C. Lachmann N, et al. Clin Transpl. 2006:171-99. Clin Transpl. 2006. PMID: 18365377

4

Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.

Lachmann N, Terasaki PI, Budde K, Liefeldt L, Kahl A, Reinke P, Pratschke J, Rudolph B, Schmidt D, Salama A, Schönemann C. Lachmann N, et al. Transplantation. 2009 May 27;87(10):1505-13. doi: 10.1097/TP.0b013e3181a44206. Transplantation. 2009. PMID: 19461487

5

Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.

Cai J, Terasaki PI, Anderson N, Lachmann N, Schönemann C. Cai J, et al. Among authors: lachmann n. Transplantation. 2009 Jul 27;88(2):226-30. doi: 10.1097/TP.0b013e3181ac6198. Transplantation. 2009. PMID: 19623018

6

Antihumoral rejection therapy by proteasome inhibitor bortezomib: a case series.

Lachmann N, Schütz M, Budde K, Schönemann C, Waiser J. Lachmann N, et al. Clin Transpl. 2009:351-8. Clin Transpl. 2009. PMID: 20527073

7

Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix(®)) in renal transplant recipients.

Brakemeier S, Schweiger B, Lachmann N, Glander P, Schönemann C, Diekmann F, Neumayer HH, Budde K. Brakemeier S, et al. Among authors: lachmann n. Nephrol Dial Transplant. 2012 Jan;27(1):423-8. doi: 10.1093/ndt/gfr278. Epub 2011 May 25. Nephrol Dial Transplant. 2012. PMID: 21613386

8

Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation.

Liefeldt L, Brakemeier S, Glander P, Waiser J, Lachmann N, Schönemann C, Zukunft B, Illigens P, Schmidt D, Wu K, Rudolph B, Neumayer HH, Budde K. Liefeldt L, et al. Among authors: lachmann n. Am J Transplant. 2012 May;12(5):1192-8. doi: 10.1111/j.1600-6143.2011.03961.x. Epub 2012 Feb 2. Am J Transplant. 2012. PMID: 22300538 Free article. Clinical Trial.

9

Prognostic value and cost-effectiveness of different screening strategies for HLA antibodies prior to kidney transplantation.

Ziemann M, Schönemann C, Bern C, Lachmann N, Nitschke M, Fricke L, Görg S. Ziemann M, et al. Among authors: lachmann n. Clin Transplant. 2012 Jul-Aug;26(4):644-56. doi: 10.1111/j.1399-0012.2012.01615.x. Epub 2012 Mar 20. Clin Transplant. 2012. PMID: 22432638

10

Identification and therapeutic management of highly sensitized patients undergoing renal transplantation.

Huber L, Lachmann N, Dürr M, Matz M, Liefeldt L, Neumayer HH, Schönemann C, Budde K. Huber L, et al. Among authors: lachmann n. Drugs. 2012 Jul 9;72(10):1335-54. doi: 10.2165/11631110-000000000-00000. Drugs. 2012. PMID: 22747448 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters